...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

Zenith might attempt to shut that trading down...

They already tried that.

FINRA will not de-link ZHCLF from Zenith, despite Zenith’s request that they do so.

 

 

Share
New Message
Please login to post a reply